{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T03:08:41Z","timestamp":1776913721409,"version":"3.51.2"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"DST - INSPIRE","award":["IF131160"],"award-info":[{"award-number":["IF131160"]}]},{"name":"Science & Engineering Research Board \u2013 Department of Science & Technology"},{"name":"University Grant Commission \u2013 Major Research Project","award":["053\/2013"],"award-info":[{"award-number":["053\/2013"]}]},{"name":"University Grant Commission \u2013 Major Research Project","award":["42-702\/2013"],"award-info":[{"award-number":["42-702\/2013"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Reports"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.pharep.2017.02.005","type":"journal-article","created":{"date-parts":[[2017,2,4]],"date-time":"2017-02-04T20:17:15Z","timestamp":1486239435000},"page":"666-672","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Esculetin ameliorates hepatic fibrosis in high fat diet induced non-alcoholic fatty liver disease by regulation of FoxO1 mediated pathway"],"prefix":"10.1007","volume":"69","author":[{"given":"Anuradha","family":"Pandey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priyank","family":"Raj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santosh Kumar","family":"Goru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Almesh","family":"Kadakol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vajir","family":"Malek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nisha","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anil Bhanudas","family":"Gaikwad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"10.1016\/j.pharep.2017.02.005_bib0005","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1159\/000282080","article-title":"Epidemiology of non-alcoholic fatty liver disease","volume":"28","author":"Bellentani","year":"2010","journal-title":"Dig Dis"},{"key":"10.1016\/j.pharep.2017.02.005_bib0010","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1002\/hep.1840360609","article-title":"NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States","volume":"36","author":"Marrero","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.pharep.2017.02.005_bib0015","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1172\/JCI24282","article-title":"Liver fibrosis","volume":"115","author":"Bataller","year":"2005","journal-title":"J Clin Investig"},{"key":"10.1016\/j.pharep.2017.02.005_bib0020","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1053\/j.gastro.2007.01.033","article-title":"The forkhead transcription factor FoxO1 regulates proliferation and transdifferentiation of hepatic stellate cells","volume":"132","author":"Adachi","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.pharep.2017.02.005_bib0025","doi-asserted-by":"crossref","first-page":"3777","DOI":"10.3748\/wjg.v21.i13.3777","article-title":"Current pharmacological therapies for nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis","volume":"21","author":"Takahashi","year":"2015","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.pharep.2017.02.005_bib0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/837939","article-title":"Herbal products: benefits, limits, and applications in chronic liver disease","volume":"2012","author":"Del Prete","year":"2012","journal-title":"Evid Based Complement Alternat Med"},{"key":"10.1016\/j.pharep.2017.02.005_bib0035","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jff.2015.03.014","article-title":"Long-term supplementation of esculetin ameliorates hepatosteatosis and insulin resistance partly by activating AdipoR2-AMPK pathway in diet-induced obese mice","volume":"15","author":"Sim","year":"2015","journal-title":"J Funct Food"},{"key":"10.1016\/j.pharep.2017.02.005_bib0040","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.cbi.2016.10.013","article-title":"Esculetin prevents non-alcoholic fatty liver in diabetic mice fed high-fat diet","volume":"260","author":"Choi","year":"2016","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.pharep.2017.02.005_bib0045","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/s10620-009-0815-3","article-title":"Characterization of high-fat, diet-induced, non-alcoholic steatohepatitis with fibrosis in rats","volume":"55","author":"Xu","year":"2010","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.pharep.2017.02.005_bib0050","doi-asserted-by":"crossref","first-page":"8364","DOI":"10.3748\/wjg.v20.i26.8364","article-title":"Experimental models of non-alcoholic fatty liver disease in rats","volume":"20","author":"Kucera","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.pharep.2017.02.005_bib0055","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jff.2015.05.017","article-title":"Esculetin reverses histone H2A\/H2B ubiquitination, H3 dimethylation, acetylation and phosphorylation in preventing type 2 diabetic cardiomyopathy","volume":"17","author":"Kadakol","year":"2015","journal-title":"J Funct Foods"},{"key":"10.1016\/j.pharep.2017.02.005_bib0060","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.biochi.2015.08.005","article-title":"Differential regulation of angiotensin converting enzyme 2 and nuclear factor-\u03baB by angiotensin II receptor subtypes in type 2 diabetic kidney","volume":"118","author":"Pandey","year":"2015","journal-title":"Biochimie"},{"key":"10.1016\/j.pharep.2017.02.005_bib0065","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.phrs.2005.05.004","article-title":"Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening","volume":"52","author":"Srinivasan","year":"2005","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.pharep.2017.02.005_bib0070","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.bbrc.2015.04.036","article-title":"Esculetin attenuates alterations in Ang II and acetylcholine mediated vascular reactivity associated with hyperinsulinemia and hyperglycemia","volume":"461","author":"Kadakol","year":"2015","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pharep.2017.02.005_bib0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bmj.g4596","article-title":"Non-alcoholic fatty liver disease","volume":"349","author":"Sattar","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.pharep.2017.02.005_bib0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1476-5926-7-6","article-title":"A new parameter using serum lactate dehydrogenase and alanine aminotransferase level is useful for predicting the prognosis of patients at an early stage of acute liver injury: a retrospective study","volume":"7","author":"Kotoh","year":"2008","journal-title":"Comp Hepatol"},{"key":"10.1016\/j.pharep.2017.02.005_bib0085","first-page":"117","article-title":"The de ritis ratio: the test of time","volume":"34","author":"Botros","year":"2013","journal-title":"Clin Biochem Rev"},{"key":"10.1016\/j.pharep.2017.02.005_bib0090","first-page":"A222","article-title":"A calculator for HOMA","volume":"47","author":"Holman","year":"2004","journal-title":"Diabetologia"},{"key":"10.1016\/j.pharep.2017.02.005_bib0095","series-title":"The oxford center for diabetes. Endocrinology & metabolism Diabetes Trial Unit","author":"Calculator","year":"2009"},{"key":"10.1016\/j.pharep.2017.02.005_bib0100","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0003-2697(79)90738-3","article-title":"Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction","volume":"95","author":"Ohkawa","year":"1979","journal-title":"Anal Biochem"},{"key":"10.1016\/j.pharep.2017.02.005_bib0105","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/0003-2697(72)90335-1","article-title":"A methodology for analysis of tissue sulfhydryl components","volume":"46","author":"Boyne","year":"1972","journal-title":"Anal Biochem"},{"key":"10.1016\/j.pharep.2017.02.005_bib0110","doi-asserted-by":"crossref","first-page":"628","DOI":"10.2353\/ajpath.2008.070601","article-title":"Late onset of CCl2 blockade with the Spiegelmer mNOX-E36-3\u2032 PEG prevents glomerulosclerosis and improves glomerular filtration rate in db\/db mice","volume":"172","author":"Ninichuk","year":"2008","journal-title":"Am J Path"},{"key":"10.1016\/j.pharep.2017.02.005_bib0115","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1002\/hep.25829","article-title":"Deletion of interleukin (IL) 12p35 induces liver fibrosis in dominant negative TGF\u03b2 receptor type II mice","volume":"57","author":"Tsuda","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.pharep.2017.02.005_bib0120","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.2337\/diacare.25.7.1135","article-title":"HOMA-estimated insulin resistance is an independent predictor of cardiovascular disease in type 2 diabetic subjects","volume":"25","author":"Bonora","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pharep.2017.02.005_bib0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.0959-9673.2006.00465.x","article-title":"Mouse models in non alcoholic fatty liver disease and steatohepatitis research","volume":"87","author":"Anstee","year":"2006","journal-title":"Int J Exp Pathol"},{"key":"10.1016\/j.pharep.2017.02.005_bib0130","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1002\/jcb.24607","article-title":"Activation of the PI3 K\/Akt pathway by oxidative stress mediates high glucose-induced increase of adipogenic differentiation in primary rat osteoblasts","volume":"114","author":"Zhang","year":"2013","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.pharep.2017.02.005_bib0135","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/ndt\/gfu196","article-title":"Potential role of Akt signaling in chronic kidney disease","volume":"30","author":"Lan","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.pharep.2017.02.005_bib0140","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1002\/hep.27368","article-title":"Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up","volume":"61","author":"Ekstedt","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.pharep.2017.02.005_bib0145","doi-asserted-by":"crossref","first-page":"S369","DOI":"10.1111\/j.1440-1746.2004.03705.x","article-title":"Pathogenesis of cirrhosis","volume":"19","author":"Wanless","year":"2004","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.pharep.2017.02.005_bib0150","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1002\/hep.24268","article-title":"Pathologic criteria for nonalcoholic steatohepatitis: interprotocol agreement and ability to predict liver-related mortality","volume":"53","author":"Younossi","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.pharep.2017.02.005_bib0155","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1055\/s-0032-1333284","article-title":"The fibrotic role of phosphatidylinositol-3-kinase\/Akt pathway in injured skeletal muscle after acute contusion","volume":"34","author":"Li","year":"2013","journal-title":"Int J Sports Med"},{"key":"10.1016\/j.pharep.2017.02.005_bib0160","doi-asserted-by":"crossref","first-page":"11278","DOI":"10.1073\/pnas.0502738102","article-title":"Acetylation of Foxo1 alters its DNA-binding ability and sensitivity to phosphorylation","volume":"102","author":"Matsuzaki","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharep.2017.02.005_bib0165","first-page":"1954","article-title":"Regulation of FoxO transcription factors by acetylation and protein\u2013protein interactions","volume":"2011","author":"Daitoku","year":"1813","journal-title":"BBA Mol Cell Res"},{"key":"10.1016\/j.pharep.2017.02.005_bib0170","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1146\/annurev.pharmtox.40.1.617","article-title":"14-3-3 proteins: structure, function, and regulation","volume":"40","author":"Fu","year":"2000","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.pharep.2017.02.005_bib0175","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.tig.2011.03.003","article-title":"Forkhead transcription factors: key players in health and disease","volume":"27","author":"Benayoun","year":"2011","journal-title":"Trends Genet"},{"key":"10.1016\/j.pharep.2017.02.005_bib0180","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1093\/jb\/mvm104","article-title":"FOXO transcription factors in the regulatory networks of longevity","volume":"141","author":"Daitoku","year":"2007","journal-title":"J Biochem"},{"key":"10.1016\/j.pharep.2017.02.005_bib0185","doi-asserted-by":"crossref","first-page":"17237","DOI":"10.1073\/pnas.0605779103","article-title":"Structural basis for protein\u2013protein interactions in the 14-3-3 protein family","volume":"103","author":"Yang","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharep.2017.02.005_bib0190","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2174\/1573399811666150804104858","article-title":"FoxO1 inhibitors: the future medicine for metabolic disorders","volume":"12","author":"Pandey","year":"2016","journal-title":"Curr Diabetes Rev"},{"key":"10.1016\/j.pharep.2017.02.005_bib0195","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1083\/jcb.201305074","article-title":"FOXO1 promotes wound healing through the up-regulation of TGF-\u03b21 and prevention of oxidative stress","volume":"203","author":"Ponugoti","year":"2013","journal-title":"J Cell Biol"},{"key":"10.1016\/j.pharep.2017.02.005_bib0200","doi-asserted-by":"crossref","first-page":"16257","DOI":"10.3390\/ijms150916257","article-title":"FOXO1, TGF-\u03b2 regulation and wound healing","volume":"15","author":"Hameedaldeen","year":"2014","journal-title":"Int J Mol Sci"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114016302110?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114016302110?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T20:36:57Z","timestamp":1752611817000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1016\/j.pharep.2017.02.005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S1734114016302110"],"URL":"https:\/\/doi.org\/10.1016\/j.pharep.2017.02.005","relation":{},"ISSN":["1734-1140"],"issn-type":[{"value":"1734-1140","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Esculetin ameliorates hepatic fibrosis in high fat diet induced non-alcoholic fatty liver disease by regulation of FoxO1 mediated pathway","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharep.2017.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Institute of Pharmacology, Polish Academy of Sciences. Published by Elsevier Sp. z o.o. All rights reserved.","name":"copyright","label":"Copyright"}]}}